药品股全线大涨中国中药(0570.HK)收涨12.32%
格隆汇8月23日丨港股药品股全线大涨,其中,中国中药涨12.32%,金嗓子、美瑞健康国际和瀚森制药涨约8%,同仁堂科技、复星医药、四环医药涨超4%,绿叶制药、石药集团、石四药集团涨超3%。《国家基本医疗保险、工伤保险和生育保险药品目录》常规准入部分的药品名单20日挂网,医保局初步确定将128个药品纳入拟谈判准入范围,包括109个西药和19个中成药。有分析人士指出,更多药品纳入目录,相关药企收入将有望增加。另外,对中国中药近日持续上涨创逾1个月新高的走势,业内人士指出,该股在近日公布了较理想的中报业绩的基础上,在前期股价经过充分调整后,目前有对估值进行修复的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.